Home » Dutch medical AI company Thirona closes financing round

Dutch medical AI company Thirona closes financing round

by LLT Editor
28th Oct 21 10:57 am

Thirona, one of the leading companies specialised in artificial intelligence (AI) for medical image analysis, has closed its financing round with Belgian investment fund HERAN Partners and Borski Fund from the Netherlands. The proceeds of the financing round will be allocated to accelerate the Company’s transition towards market leadership in medical imaging.

Thirona, founded in 2014 by female scientist Eva van Rikxoort, has rapidly transformed from a start-up to a category leader in the field of AI-powered medical image analysis. With its diverse team of sixty employees driven by an inclusive innovation culture, the Company develops highly innovative artificial intelligence solutions for both lung and retinal image analysis. Apart from focusing on the most common diseases such as Asthma, COPD, Age-related Macular Degeneration and Diabetic Retinopathy, Thirona is also tackling rare and complex conditions, such as Cystic Fibrosis and Idiopathic Pulmonary Fibrosis.

“We believe that science should be used for the benefit of all people. Our vision is to speed up scientific progress in healthcare by bringing together the best of science and technology. This to enable breakthroughs in treatment development and clinical care,” Eva van Rikxoort, founder and CEO of Thirona, says.

Thirona focuses on translating AI-based technology into value-adding solutions and services in the entire spectrum of the clinical user – from clinical trials to clinics – through partnerships and integrations. With its flagship product, LungQ, Thirona has built a proven track record as an expert partner for pharmaceutical companies, helping to advance treatment development in clinical trials, as well as supporting pulmonary clinical care across the globe.

Now that it is closing in on 10 million images analysed and its solutions have been validated in over 180 scientific publications, Thirona is looking to expand its operations and scale up its development efforts. Guido Geerts (co-CEO of Thirona) comments: “As a company, we have always placed a high emphasis on research and development which has enabled us to establish strong academic, clinical and industrial partnerships. Now, we find ourselves at a tipping point in our journey, expediting our international expansion and development goals. We are pleased to have found the right partners in HERAN Partners and Borski Fund to help accelerate our growth trajectory.”

Leave a Comment

You may also like